Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

34
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
34
Dialysis01:27

Dialysis

228
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
228
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

30
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
30
Kidney Structure01:45

Kidney Structure

66.8K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
66.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Robotic recipient liver transplantation worldwide: a systematic review and meta-analysis of the first 93 patients, from feasibility to early outcomes.

EClinicalMedicine·2026
Same author

Evidence rising, integration lagging: the bottleneck of circulating free and tumor DNA application in liver transplantation for hepatocellular carcinoma.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2026
Same author

Correction: Gender disparities in liver transplantation.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Reply: Estimating the cost of liver transplantation.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and post-transplant management of non-graft-related complications.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2025
Same author

Role of antibiotic prophylaxis in liver transplant patients undergoing endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis.

EClinicalMedicine·2025

相关实验视频

Updated: May 10, 2025

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

7.7K

功能障碍和肝移植

Shilpa Junna1, Sarah Nasser2, Pratima Sharma3

  • 1Mikati Center for Liver Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA. Electronic address: https://twitter.com/gishilpz.

Clinics in liver disease
|April 26, 2025
PubMed
概括
此摘要是机器生成的。

肝移植评估经常显示功能障碍. 肝病学家必须了解诊断和管理急性损伤 (AKI) 和慢性病,以获得最佳的肝移植 (LT) 结果.

关键词:
急性损伤是什么?急性损伤是什么?肝综合征是一种肝综合征.肝脏移植是什么?肝移植是什么?周周移植 周周移植移植后的情况同时发生肝脏脏.

更多相关视频

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

15.5K
Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:26

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

343

相关实验视频

Last Updated: May 10, 2025

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

7.7K
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

15.5K
Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:26

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

343

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 肝病学 肝病学是一种肝病学.
  • 移植 移植 移植 移植

背景情况:

  • 功能障碍是评估肝移植 (LT) 患者的常见并发症.
  • 有效的病管理对于成功的LT结果至关重要.
  • 肝病学家需要全面了解LT候选人的功能障碍.

研究的目的:

  • 在肝移植的背景下,审查急性损伤 (AKI) 和慢性病的诊断和管理.
  • 在LT候选人中概述优化治疗功能障碍的策略.
  • 讨论替代疗法在接受LT评估的患者中的作用.

主要方法:

  • 文献综述侧重于移植前,移植前和移植后的AKI.
  • 分析当前的指导方针和证据,以管理LT接受者的病.
  • 关于LT候选人的置换疗法信息的综合.

主要成果:

  • AKI和慢性病显著影响LT的结果.
  • 及时诊断和适当管理功能障碍是必不可少的.
  • 脏替代疗法在LT候选人的末期脏病管理中起着至关重要的作用.

结论:

  • 肝病学家必须熟练地管理整个LT过程中的功能障碍.
  • 在移植前优化功能可以改善LT后的结果.
  • 肝脏病学和肝脏病学之间的综合护理对于肝脏移植的成功至关重要.